Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 1 4Phase 3 3Phase 1/2 2Phase 4 1

Status

Completed 13Recruiting 7Terminated 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Oesophago-gastric Cancer 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Panitumumab × Clear all
NCT03300609 2020-06-11

5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

University of Southern California

Phase 3 Terminated
4 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01627379 2018-03-02

POWER

AIO-Studien-gGmbH

Phase 3 Terminated
300 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated
574 enrolled
Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡